CTICasesCheckpoint Inhibitor-Induced Thyroiditis
Imaging findings
Comparison between pre- and post-treatment scans shows a transition from a healthy, iodine-avid thyroid gland to an atrophied, poorly visible gland. PET/CT imaging revealed hypermetabolic uptake in the thyroid consistent with active thyroiditis during the inflammatory phase.
Key takeaways
Checkpoint inhibitors like pembrolizumab can cause diffuse gland inflammation that leads to permanent damage and atrophy, often resulting in the patient requiring lifelong thyroid hormone replacement therapy.
AI-assisted summary — may contain errors. Verify against the source video. Learn more
More from this webinar
- Pseudo-coarctation of the AortaCongenital
- Relapsing PolychondritisAutoimmune
- Disseminated TuberculosisInfection
- Aorto-Esophageal FistulaInfection
See all cases from May 1, 2024 →